1i5x: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
No edit summary
OCA (talk | contribs)
No edit summary
Line 1: Line 1:
[[Image:1i5x.gif|left|200px]]
{{Seed}}
[[Image:1i5x.png|left|200px]]


<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1i5x|  PDB=1i5x  |  SCENE=  }}  
{{STRUCTURE_1i5x|  PDB=1i5x  |  SCENE=  }}  


'''HIV-1 GP41 CORE'''
===HIV-1 GP41 CORE===




==Overview==
<!--  
Membrane fusion by human immunodeficiency virus type 1 (HIV-1) is promoted by the refolding of the viral envelope glycoprotein into a fusion-active conformation. The structure of the gp41 ectodomain core in its fusion-active state is a trimer of hairpins in which three antiparallel carboxyl-terminal helices pack into hydrophobic grooves on the surface of an amino-terminal trimeric coiled coil. In an effort to identify amino acid residues in these grooves that are critical for gp41 activation, we have used alanine-scanning mutagenesis to investigate the importance of individual side chains in determining the biophysical properties of the gp41 core and the membrane fusion activity of the gp120-gp41 complex. Alanine substitutions at Leu-556, Leu-565, Val-570, Gly-572, and Arg-579 positions severely impaired membrane fusion activity in envelope glycoproteins that were for the most part normally expressed. Whereas alanine mutations at Leu-565 and Val-570 destabilized the trimer-of-hairpins structure, mutations at Gly-572 and Arg-579 led to the formation of a stable gp41 core. Our results suggest that the Leu-565 and Val-570 residues are important determinants of conserved packing interactions between the amino- and carboxyl-terminal helices of gp41. We propose that the high degree of sequence conservation at Gly-572 and Arg-579 may result from selective pressures imposed by prefusogenic conformations of the HIV-1 envelope glycoprotein. Further analysis of the gp41 activation process may elucidate targets for antiviral intervention.
The line below this paragraph, {{ABSTRACT_PUBMED_11602754}}, adds the Publication Abstract to the page
(as it appears on PubMed at http://www.pubmed.gov), where 11602754 is the PubMed ID number.
-->
{{ABSTRACT_PUBMED_11602754}}


==About this Structure==
==About this Structure==
Line 28: Line 32:
[[Category: Hiv-1 inhibition]]
[[Category: Hiv-1 inhibition]]
[[Category: Membrane fusion]]
[[Category: Membrane fusion]]
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri May 2 19:37:05 2008''
 
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jul 1 10:28:20 2008''